Latest filing published 03 Apr 2017 for Cipher Pharmaceuticals Inc..
This profile gathers the share dealings of Mark Spina in Cipher Pharmaceuticals Inc. We count 12 filings; the first trade dates from 18 January 2016 and the latest from 15 March 2017.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
The newest entry dates from 3 April 2017: an option exercise, in Cipher Pharmaceuticals Inc. Filings reach the SEDI feed a median of 5 days after the trade. This delay matters because a trade only becomes useful information once it is public. These figures are compiled from regulatory filings published by SEDI. They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
12 of 12 declarations